Piedmont Investment Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-12,368
Closed -$717K 231
2020
Q1
$717K Buy
12,368
+1,937
+19% +$157K 0.03% 357
2019
Q4
$965K Buy
10,431
+972
+10% +$85.5K 0.03% 337
2019
Q3
$855K Buy
9,459
+81
+0.9% +$9.23K 0.03% 361
2019
Q2
$1.11M Buy
9,378
+564
+6% +$56.8K 0.04% 302
2019
Q1
$763K Buy
8,814
+38
+0.4% +$3.23K 0.03% 364
2018
Q4
$554K Buy
8,776
+33
+0.4% +$2.27K 0.03% 421
2018
Q3
$690K Buy
8,743
+8,664
+10,967% +$565K 0.03% 398
2018
Q2
$5K Buy
+79
New +$4.25K ﹤0.01% 2106
2018
Q1
Sell
-4,695
Closed -$247K 781
2017
Q4
$247K Sell
4,695
-6,210
-57% -$332K 0.01% 637
2017
Q3
$514K Buy
+10,905
New +$439K 0.01% 417

Other funds holding EXAS

Piedmont Investment Advisors's EXAS Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Exact Sciences (EXAS) in Q2 2020, closing a stake of 12,368 shares — an estimated $717K sold.

Piedmont Investment Advisors first reported a position in EXAS in Q3 2017 and held it in 10 quarters. The position peaked at $1.11M in Q2 2019. 513 funds tracked by Wall St. Rank hold EXAS as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Exact Sciences position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 12,368 Exact Sciences shares in Q2 2020, an estimated $717K.
  • Piedmont Investment Advisors first reported a position in Exact Sciences in Q3 2017 and held it in 10 quarters.
  • Piedmont Investment Advisors's Exact Sciences position peaked at $1.11M in Q2 2019.
  • 513 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.